Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1983-03-21
1985-01-29
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 15, 544125, 514231, C07D48908, A61K 31485
Patent
active
044965702
ABSTRACT:
Compounds the structural formula ##STR1## or their pharmaceutically acceptable salts, wherein X is H or CH.sub.3, Z is NH.sub.2 or OR.sub.6, R.sub.1 is a C.sub.1-8 alkyl, C.sub.3-6 -cycloalkylmethyl, or phenyl-C.sub.1-2 alkyl group,
REFERENCES:
patent: 2619485 (1952-11-01), Chabrier et al.
patent: 4362870 (1982-12-01), Portoghese
Hazum et al., Biochemical and Biophysical Research Communications, vol. 104, pp. 347-353, (01/15/82).
British Drug Houses, Ltd., Chemical Abstracts, vol. 61, 4365e-4366d, (1964).
Daus Donald G.
Key Pharmaceuticals, Inc.
Rivers Diana G.
LandOfFree
4,5.alpha.Epoxymorphinan -6-spiro-2'-(4'-carboxy,1',3'-thiazolid does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4,5.alpha.Epoxymorphinan -6-spiro-2'-(4'-carboxy,1',3'-thiazolid, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4,5.alpha.Epoxymorphinan -6-spiro-2'-(4'-carboxy,1',3'-thiazolid will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-506276